Update #14 on Avastin vs Lucentis

Discussion in 'Optometry Archives' started by Irv Arons, Jun 7, 2007.

  1. Irv Arons

    Irv Arons Guest

    For those of you who may be interested, I have posted an update to my
    series of articles on the Avastin vs. Lucentis controversy on my web
    site. The subject is a commentary about the June 5th WSJ article
    wherein Genentech's CEO tried to justify the price differential
    between the two drugs for use in treating age-related macular
    degeneration. The commentary is written by an attorney involved in the
    biotech area.

    The update link is: http://irvaronsjournal.blogspot.com/2007/06/avastinlucentis-update-14-genentech-ceo.html

    Irv Arons
     
    Irv Arons, Jun 7, 2007
    #1

    1. Advertisements

  2. Irv Arons

    michael toulch Guest

    interesting link and story.
     
    michael toulch, Jun 7, 2007
    #2

    1. Advertisements

Ask a Question

Want to reply to this thread or ask your own question?

You'll need to choose a username for the site, which only take a couple of moments (here). After that, you can post your question and our members will help you out.
Similar Threads

  1. Update: Latest Info on Lucentis and Avastin for Treating AMD

  2. Update on Avastin and Lucentis in the Untited Kingdom

  3. Avistan Update 5: NIH Considers Trial Comparing Lucentis to Avistan

  4. FDA warning on Avastin has few implications for ophthalmic use, investigator says

  5. Disturbing News about Avastin vs Lucentis Trial

  6. Avastin vs Lucentis: The Germans have joined the battle!

  7. CATT Clinical Sites -- Avastin vs Lucentis

  8. Canadian Healthcare Struggles with Avastin vs. Lucentis Controversy

Loading...